水素ガスがアルツハイマー病モデルにおける毒性代謝物・酸化ストレスシグナルを抑制し神経変性防止と記憶改善に寄与する
Alzheimer's disease (AD) involves amyloid-beta (Aβ) plaque-driven oxidative stress and neuroinflammation leading to memory impairment. Reactive astrocytes further contribute to neurodegeneration through toxic metabolite accumulation within the astrocytic urea cycle. This study examined whether 3% hydrogen gas (H2) inhalation over 60 days could counteract these processes in 5xFAD mice (n=14) and wild-type controls (n=15). Cognitive performance was assessed via Morris water maze and Y-maze tests. Hippocampal ammonia and hydrogen peroxide levels were quantified biochemically, and Aβ, GABA, and inflammatory marker expression were evaluated by immunohistochemistry and qRT-PCR in both mouse hippocampi and Aβ oligomer-treated primary astrocytes. H2-treated 5xFAD mice showed significant reductions in cognitive deficits, oxidative stress markers, toxic metabolite accumulation, and inflammatory signaling compared with vehicle controls, suggesting that H2 inhalation modulates the astrocytic urea cycle to limit neurodegeneration.
H2 inhalation suppresses accumulation of toxic metabolites (ammonia and hydrogen peroxide) in the astrocytic urea cycle, thereby attenuating oxidative stress and Aβ-associated inflammatory signaling to limit neurodegeneration.
For inhalation applications of molecular hydrogen, the lower flammability limit (LFL) deserves careful handling. The classical 4% figure applies to closed-system mixtures; the practical inhalation-environment threshold is 10%. Even pure-hydrogen output (the UFL 75% paradox) passes through the flammable range at the air–gas boundary. High-concentration (66% / 100%) inhalers are documented in the Japanese Consumer Affairs Agency accident-information database and are not recommended.
See also:
https://h2-papers.org/en/papers/40725167